- December 08, 2023Source: ASCO Post
Genetic Characteristics of HER2-Low Advanced Breast Cancers May Guide Treatment Selection
- December 08, 2023
New Research Reveals How Modifying a Key Molecular Regulator Could Improve the Treatment of von Willebrand Disease
- December 08, 2023
Disparities in Breast Reconstruction Rates After Mastectomies for Older Asian American and South Korean Women
- December 07, 2023Source: YaleNews
Study Reveals Cancer Cells’ Resistance — and Vulnerability — to Treatment
- December 07, 2023Source: Yale Insights
Tara Sanft: Life after Cancer
- December 07, 2023Source: NBC News
New sickle cell treatment sparks feelings of hope and some hesitancy among Black patients
- December 07, 2023Source: The ASCO Post
Novel Selective Biomarker May Help Select Effective Targeted Therapies in Patients With Metastatic Breast Cancer
- December 06, 2023
Care for Pregnant Persons with Sickle Cell Disease
- December 06, 2023
Study: Patient’s Genetic Characteristics May Help Differentiate HER2-Low Advanced Breast Cancers and Guide Treatment Selection
- December 06, 2023
New Research Sheds Light on Equitable Treatment Options for Pediatric Patients With Sickle Cell Disease
- December 05, 2023
Human and planetary health benefits of olive oil focus of fifth annual International Yale Symposium
- December 05, 2023
Yale Cancer Center Physicians Bring Myeloma Message to Hamden’s Newhall Neighborhood
- December 05, 2023
Smilow Shares with Primary Care: Liver Cancer
- December 04, 2023
Yale Cancer Answers: Healing During the Holidays
- December 04, 2023
Phase 3 Results Offer Hope for Patients With Myelodysplastic Syndromes
- December 04, 2023
Study: New Biomarker Tool Helps Select Targeted Therapies to Treat Metastatic Breast Cancers
- December 02, 2023Source: My Record Journal
Editorial: A back-on-track cancer treatment center is good news for Wallingford
- December 01, 2023Source: Connecticut Public Radio
Connecticut prisons likely under-screen, under-diagnose cancer, study finds
- December 01, 2023Source: OncLive
Dr. Zeidan on Classification and Treatment Updates in MDS
- December 01, 2023Source: SWOG
Lung-MAP Shows Potential of Public-Private Partnerships
Research and Education
In the fight against cancer, Yale has been at the forefront of understanding the fundamental mechanisms of cancer biology and in developing effective therapies for the treatment of cancer. Yale Cancer Center harnesses the resources of Yale School of Medicine and Yale New Haven Hospital to advance cancer research, prevention, and patient care, as well as community outreach and education.
Publications
828 Publications - June 30, 2021-July 1, 2022
213 High Impact Publications, including:
- 41 - Nature/Nature Speciality
- 21 - Clinical Cancer Research
- 19 - Journal for Immunotherapy of Cancer
- 14 - Journal of Clinical Oncology
- 11 - Science/Science Specialty
- 10 - Journal of National Cancer Institute
- 9 - JAMA/JAMA Oncology
- 7 - Journal of Thoracic Oncology
- 7 - New England Journal of Medicine
- 6 - Cancer Discovery
- 5 - Cell/Cell Specialty
- 4 - Molecular Cell
- 4 - Lancet/Lancet Oncology